Yahoo India Web Search

Search results

  1. Respiri develops and sells wheezo®, a medical device and app that can detect wheeze in patients. It also offers Respiri health portal, a cloud-based platform for physicians to monitor and manage wheeze data.

    • Respiri AU

      Respiri Limited (ASX:RSH, OTCQB:RSHUF) is an Australian...

    • Respiri Us

      Respiri can integrate wheezo® medical device and wheeze...

    • Respiri UK

      wheezo ® is a breath sensor that works with the respiri TM...

    • Investor Centre

      For any queries on Respiri’s OTC trading please feel free to...

    • Contact

      Respiri Australia - Care Beyond the Clinic Menu Home; About;...

    • Cookie Policy

      Cookie Policy - Respiri makers of wheezo® & Respiri Limited...

    • ASX Announcements

      Whether you’re a shareholder or not you can subscribe to...

    • Respiri Annual Reports

      Investor Centre Menu. Investor Centre. Corporate Governance....

  2. Respiri Limited (ASX:RSH, OTCQB:RSHUF) is an Australian e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US healthcare market. Respiri is listed on the Australian Securities Exchange (ASX) and trades on the OTCQB under the ticker “RSHUF” for North American based investors

  3. Respiri can integrate wheezo® medical device and wheeze detection into remote patient monitoring programs to claim CPT codes.

    • Respiri1
    • Respiri2
    • Respiri3
    • Respiri4
    • Respiri5
  4. Respiri Limited is uniquely positioned to revolutionise chronic disease management globally and is focused on the US market, where our suite of evidence-based programs qualify for Current Procedural Terminology (CPT) Code reimbursement.

  5. As a differentiated RPM provider, Respiris mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and, exclusively, respiratory disease.

  6. Oct 31, 2019 · The latest Respiri Limited [RSH] news, articles, data and analysis from The Australian Financial Review.

  7. People also ask

  8. Nov 8, 2022 · Australian digital health company Respiri has started to roll out its digital remote patient monitoring (RPM) system for asthma and chronic obstructive pulmonary disease (COPD) in the US, with...